Slotta-Huspenina J - Search Results

1

Gut microbiota modulate T cell trafficking into human colorectal cancer.

Cremonesi E, Governa V, Garzon JFG, Mele V, Amicarella F, Muraro MG, Trella E, Galati-Fournier V, Oertli D, Däster SR, Droeser RA, Weixler B, Bolli M, Rosso R, Nitsche U, Khanna N, Egli A, Keck S, Slotta-Huspenina J, Terracciano LM, Zajac P, Spagnoli GC, Eppenberger-Castori S, Janssen KP, Borsig L, Iezzi G. Cremonesi E, et al. Gut. 2018 Nov;67(11):1984-1994. doi: 10.1136/gutjnl-2016-313498. Epub 2018 Feb 6. Gut. 2018. PMID: 29437871 Free article.

2

Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collective.

Nitsche U, Maak M, Schuster T, Künzli B, Langer R, Slotta-Huspenina J, Janssen KP, Friess H, Rosenberg R. Nitsche U, et al. Ann Surg. 2011 Nov;254(5):793-800; discussion 800-1. doi: 10.1097/SLA.0b013e3182369101. Ann Surg. 2011. PMID: 22042471

3

High HSP27 and HSP70 expression levels are independent adverse prognostic factors in primary resected colon cancer.

Bauer K, Nitsche U, Slotta-Huspenina J, Drecoll E, von Weyhern CH, Rosenberg R, Höfler H, Langer R. Bauer K, et al. Cell Oncol (Dordr). 2012 Jun;35(3):197-205. doi: 10.1007/s13402-012-0079-3. Epub 2012 Apr 26. Cell Oncol (Dordr). 2012. PMID: 22535481

4

Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer.

Nitsche U, Rosenberg R, Balmert A, Schuster T, Slotta-Huspenina J, Herrmann P, Bader FG, Friess H, Schlag PM, Stein U, Janssen KP. Nitsche U, et al. Ann Surg. 2012 Nov;256(5):763-71; discussion 771. doi: 10.1097/SLA.0b013e318272de87. Ann Surg. 2012. PMID: 23095620

5

Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis.

Nitsche U, Zimmermann A, Späth C, Müller T, Maak M, Schuster T, Slotta-Huspenina J, Käser SA, Michalski CW, Janssen KP, Friess H, Rosenberg R, Bader FG. Nitsche U, et al. Ann Surg. 2013 Nov;258(5):775-82; discussion 782-3. doi: 10.1097/SLA.0b013e3182a69f7e. Ann Surg. 2013. PMID: 23989057 Free PMC article.

6

Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer.

Malinowsky K, Nitsche U, Janssen KP, Bader FG, Späth C, Drecoll E, Keller G, Höfler H, Slotta-Huspenina J, Becker KF. Malinowsky K, et al. Br J Cancer. 2014 Apr 15;110(8):2081-9. doi: 10.1038/bjc.2014.100. Epub 2014 Mar 11. Br J Cancer. 2014. PMID: 24619078 Free PMC article.

7

Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma.

Drecoll E, Nitsche U, Bauer K, Berezowska S, Slotta-Huspenina J, Rosenberg R, Langer R. Drecoll E, et al. Int J Colorectal Dis. 2014 Jun;29(6):663-71. doi: 10.1007/s00384-014-1857-3. Epub 2014 Apr 15. Int J Colorectal Dis. 2014. PMID: 24733427 Free article.

8

Computerized analysis of enhancement kinetics for preoperative lymph node staging in rectal cancer using dynamic contrast-enhanced magnetic resonance imaging.

Vag T, Slotta-Huspenina J, Rosenberg R, Bader FG, Nitsche U, Drecoll E, Rummeny EJ, Gaa J. Vag T, et al. Clin Imaging. 2014 Nov-Dec;38(6):845-9. doi: 10.1016/j.clinimag.2014.06.011. Epub 2014 Jun 19. Clin Imaging. 2014. PMID: 25082173

9

Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit.

Geyer PE, Maak M, Nitsche U, Perl M, Novotny A, Slotta-Huspenina J, Dransart E, Holtorf A, Johannes L, Janssen KP. Geyer PE, et al. Mol Cancer Ther. 2016 May;15(5):1008-17. doi: 10.1158/1535-7163.MCT-15-0633. Epub 2016 Jan 29. Mol Cancer Ther. 2016. PMID: 26826119

10

Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing.

Schmiegel W, Scott RJ, Dooley S, Lewis W, Meldrum CJ, Pockney P, Draganic B, Smith S, Hewitt C, Philimore H, Lucas A, Shi E, Namdarian K, Chan T, Acosta D, Ping-Chang S, Tannapfel A, Reinacher-Schick A, Uhl W, Teschendorf C, Wolters H, Stern J, Viebahn R, Friess H, Janssen KP, Nitsche U, Slotta-Huspenina J, Pohl M, Vangala D, Baraniskin A, Dockhorn-Dworniczak B, Hegewisch-Becker S, Ronga P, Edelstein DL, Jones FS, Hahn S, Fox SB. Schmiegel W, et al. Mol Oncol. 2017 Feb;11(2):208-219. doi: 10.1002/1878-0261.12023. Epub 2017 Jan 20. Mol Oncol. 2017. PMID: 28106345 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page